A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis
- SR Muthuramalingam
- , JP Braybrooke
- , Andrew Blann
- , S Madhusudan
- , S Wilner
- , A Jenkins
- , C Han
- , K Kaur
- , T Perren
- , TS Ganesan
Research output: Contribution to journal › Article
5
Citations
(Scopus)